Porphyromonas (Bacteroides) gingivalis W12 binds and degrades human plasma fibronectin. In the presence of the protease inhibitor N-a-p-tosyl-L-lysyl chloromethyl ketone, P. gingivalis cells accumulated substantial amounts of '2,I-fibronectin as a function of incubation time. Fibronectin binding was specific, reversible, and 
proteins were without effect on fibronectin binding. A fibronectin-binding component (Mr, 150 ,000) was identified in sodium dodecyl sulfate-solubilized P. gingivalis. Fibronectin was degraded into discrete peptides by P. gingivalis W12. The degradation of fibronectin was inhibited by N-a-p-tosyl-L-lysyl chloromethyl ketone. Two P. gingivalis components (M,s, 120,000 and 150,000) degraded fibronectin in substrate-containing gels following sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In a previous study (M. S. Lantz, R. D. Allen, T. A. Vail, L. M. Switalski, and M. Hook, J. Bacteriol. 173:495-504, 1991), we found that the same strain of P. gingivalis bound and subsequently degraded human fibrinogen via apparently distinct cell surface components of molecular sizes similar to those of components now implicated in the binding and degradation of fibronectin. These results raise the possibility that the two ligands are recognized and modified by the same components on P. gingivalis W12. In support of this hypothesis, unlabeled fibrinogen effectively inhibited the binding of 1251-fibronectin to bacteria and blocked '2,I-fibronectin binding to a P. gingivalis ligand-binding component (M,, 150,000) immobilized on a nitrocellulose membrane.
Fibronectin is a multifunctional dimeric adhesive protein (molecular mass, -440 kDa) found on cell surfaces, in extracellular matrices, and in body fluids, such as plasma (23) . It is believed to play an important role in cell-matrix interactions by serving as a substrate for eukaryotic cell adhesion and migration. Fibronectin binds specifically to a number of extracellular matrix molecules, including collagens, glycosaminoglycans, proteoglycans, fibrinogen, and fibrin (see reference 25 for a recent review). Kuusela first reported that a bacterium, Staphylococcus aureus, can bind fibronectin (11) , and it has since been proposed that the binding of bacterial cells to fibronectin may represent a mechanism of tissue adherence (32) . Fibronectin has been reported to bind to a variety of gram-positive and gramnegative bacteria, including strains of S. aureus (2, 5, 11, 24, 26) , coagulase-negative staphylococci (33) , group A, C, and G streptococci (20, 29, 32) , Salmonella enteritidis (1), Escherichia coli (4) , and Treponema pallidum (22) . In some cases, bacterial binding to fibronectin has been shown to be mediated by specific receptor proteins located on the surface of bacterial cells (5, 22, 28, 36) . Some bacteria, for example, S. aureus (8) , Streptococcus sanguis (17) , T. pallidum (36) , and E. coli (4) , have been shown to adhere to fibronectincoated surfaces.
Fibronectin is also degraded by bacteria. A number of gram-negative pathogenic bacteria, including Pseudomonas aeruginosa (40) , Serratia marcescens (19) , and Vibrio cholerae (3), produce fibronectin-degrading enzymes. Wikstrom and Linde (38) concluded that fibronectin-degrading ability is periodontitis, coupled with our recent findings (13) , which suggest that protein ligands can be effectively degraded after they are bound to P. gingivalis, prompted us to examine further the interaction between soluble fibronectin and P. gingivalis.
MATERIALS AND METHODS
Chemicals. Human fibronectin (lyophilized with sucrose and phosphate buffer; New York Blood Center) was reconstituted with water at room temperature (10 mg/ml final concentration) according to the manufacturer's instructions, dialyzed to phosphate-buffered saline (PBS; 0.13 M sodium chloride, 10 mM phosphate buffer, 0.02% sodium azide [pH 7.4]), and used without further purification. Fibronectin was labeled with 1251 by the chloramine T method (9) as previously described (15) . The specific activity of the labeled fibronectin was estimated to be 4.2 x 106 cpm/ Rg. Human fibrinogen (Kabi, Stockholm, Sweden) was purified and labeled with 1251 as previously described (15) . The specific activity of the 1251-fibrinogen was estimated to be 1.7 x 106 cpm/,ug. D fragments of fibrinogen were prepared as previously described (12) . Plasminogen-free human fibrinogen was purchased from Sigma and used in substrate gels (zymograms) without further purification. The purity and structural integrity of unlabeled and labeled proteins were determined by polyacrylamide gel electrophoresis (PAGE) in sodium dodecyl sulfate (SDS) under reducing and nonreducing conditions by the method of Studier (31) . The resolving gel was 7.5% polyacrylamide and was overlaid with a 4.8% stacking gel. Samples were dissolved in sample buffer containing 4% (wt/vol) SDS. After electrophoresis, gels were stained with Coomassie brilliant blue R, dried, and subjected to autoradiography with either Kodak X-Omat AR or Eastman Diagnostic Blue Brand film (Eastman Kodak Co., Rochester, N.Y.).
Bovine serum albumin (BSA), chicken egg albumin (ovalbumin), human ao-acid glycoprotein (orosomucoid), human immunoglobulin G, bovine fetuin, Triton X-100, N-ot-ptosyl-L-lysyl chloromethyl ketone (TLCK), and dithiothreitol (DTT) were purchased from Sigma. Na1251I (specific activity, 15 mCi/,ug) was purchased from Amersham Corp. (Arlington Heights, Ill.). All other chemicals were of reagent grade and were obtained from commercial sources.
Bacteria. P. gingivalis W12 was grown from stock strains maintained in the Anaerobic Core Facility, University of Alabama School of Dentistry. Bacteria used in the experiments were stored and maintained as previously described (13) . Bacteria used in the experiments were grown in complete basal anaerobic broth (34) at 37°C under anaerobic conditions. After growth to the early logarithmic phase (approximately 108 cells per ml after 16 h of growth), bacteria were harvested by centrifugation (13,000 x g; 20 min), washed three times with PBS, and resuspended in the same buffer. Bacteria were counted with a Petroff-Hauser chamber, and suspensions were adjusted to contain 1 x 1010 cells per ml (optical density at 540 nm, =2.0) or 2 x 1010 cells per ml (optical density at 540 nm, =4.0) and stored at 4°C as previously described (14) .
Binding of 1251-fibrinogen and 1251-fibronectin to bacteria. Binding of 1251-labeled protein to P. gingivalis W12 was determined as previously described (13, 14) . In Degradation of 125I-fibronectin by P. gingivalis W12. The extent of degradation of '25I-fibronectin by P. gingivalis and the relative molecular weights of the fibronectin fragments produced were determined by SDS-PAGE on linear 3 to 9% gradient polyacrylamide gels (13) and by autoradiography as described above. Bacteria (2.5 x 108 cells) were incubated with 1251I-fibronectin (5 x 105 cpm) in PBS-BSA in a final volume of 0.5 ml. In some incubation mixtures, the protease inhibitor TLCK (30 mM final concentration) was included. Incubations were performed at 4, 22, and 37°C for 15 min toto displace bound iodinated fibronectin or fibronectin fragments. At the end of this second incubation period, which was performed to prevent further proteolysis of 124-fibronectin during preparation of the samples for electrophoresis (see below), the bacteria were removed from the incubation mixture by centrifugation and 125I-labeled material displaced from the bacteria by fibrinogen, as well as any iodinated material still bound to the bacteria, was analyzed by SDS-PAGE and autoradiography.
Identification of fibronectin-degrading components of P. gingivalis W12 by substrate gel electrophoresis. Substrate gels were used as previously described (13) to identify components of P. gingivalis W12 that degrade human fibronectin or fibrinogen. In brief, plasminogen-free human fibronectin or fibrinogen (1 mg/ml final concentration) was added to 3 and 9% acrylamide solutions prior to casting of the gel, and the protein was copolymerized with the gel. P. gingivalis components solubilized in 4% SDS (wt/vol) were mixed with sample buffer and subjected to SDS-PAGE. After electrophoresis, the gel was washed first with 2.5% Triton X-100 in distilled water, then with 2.5% Triton X-100 in PBS, and finally with PBS. The washing procedure was performed over a 1-h period to remove SDS. For activation of proteolytic enzymes, the washed gel was incubated in PBS or Tris-buffered saline containing 10 mM DTT for 16 h at 37°C.
Finally, the gel was fixed in 50% methanol-7% acetic acid and stained with 0.23% Coomassie brilliant blue R in 30% methanol-5.8% acetic acid. Proteolytic enzymes active in the gel were visualized as clear bands against the blue background of the gel after destaining.
RESULTS
Binding of 1251-fibronectin to bacteria. We examined 1251_ fibronectin binding to P. gingivalis W12 as a function of time and temperature and found that bacteria accumulated iodinated fibronectin only in the presence of TLCK, a protease inhibitor. In the absence of protease inhibitors, only about 3% of the 1251-fibronectin added became associated with the cells over a 3-h incubation period at 4°C (Fig. 1) . In the presence of TLCK, significant amounts of 1251-fibronectin bound to bacteria. At 4°C, a maximum of 20% of the added ligand bound to the bacterial cells after a 1-h incubation period. This amount corresponds to approximately 2.4 ng of fibronectin bound per 2.5 x 108 bacterial cells. In a previous study, we found that these bacteria accumulated 125i-fibrinogen at 4°C whether or not a protease inhibitor was included in the incubation mixtures (13) .
We used SDS-PAGE and autoradiography to examine the effects of temperature and the presence of TLCK on the degradation of 1251-fibronectin associated with the cells or recovered from the supernatant after incubations similar to those described above. The results indicated that in the absence of TLCK, most of the labeled fibronectin present in the incubation mixtures after 3 h at 4°C was found intact in the supernatant fraction ( Fig. 2A, lane 2) . Small amounts of fibronectin degradation products were also present. Only a relatively small proportion of the total 1251-fibronectin was associated with bacteria ( Fig. 2A, lane 3) , and a substantial portion of the cell-associated fibronectin occurred as degradation products. When bacteria were incubated with 12511 fibronectin at 22°C for 1 h, intact fibronectin as well as significant amounts of discrete fibronectin fragments were found in the supernatant fraction ( Fig. 2A, lane 5) , and small amounts of fibronectin degradation products were associated with bacteria ( Fig. 2A, lane 6) . After 3 h of incubation of Binding of 1251-fibronectin to P. gingivalis W12 was at least partially reversible, since greater than 60% of bound iodinated fibronectin was rapidly displaced by unlabeled fibronectin (Fig. 3) . Unlabeled fibrinogen could also displace bound 1251I-fibronectin and its degradation products from P. gingivalis W12 ( Fig. 2A and B, lanes 3, 4, 6 (Fig. 4A) . These data suggest that bacteria possess a limited number of fibronectin binding sites. Analysis of the binding data by the Scatchard method (27) (Fig. 4A, inset) (27) (Fig. 4B, inset) were blocked by exposure to BSA, and the membrane was incubated in a solution containing 1251-fibronectin. After being extensively washed, the membrane was dried and 1251-fibronectin bound to the membrane was detected by autoradiography. A fibronectin-binding component (Mr, 150,000) was identified by this technique (Fig. 5) . A fibrinogen-binding component of the same relative size was demonstrated when a nitrocellulose membrane containing electroblotted P. gingivalis components was probed with 1251_ fibrinogen (Fig. 5) , consistent with our previous data (13) .
To study the binding specificity of the Mr-150,000 P. gingivalis component(s), we conducted a series of experiments in which strips of nitrocellulose membrane containing P. gingivalis components were incubated with various unlabeled proteins and washed extensively prior to exposure to 125I-labeled ligand (Fig. 6 ). An 6A) . Identification of fibronectin-degrading components of P. gingivalis W12. Zymography was tried in attempts to identify fibronectin-degrading P. gingivalis components. In this approach, bacterial components solubilized by SDS are fractionated in a polyacrylamide gel containing copolymerized fibronectin. After the SDS is removed, the gel is incubated in a buffered DTT solution to activate proteases. The gel is finally fixed and stained. The presence of an active fibronectin-degrading component is indicated by a clearing zone in the gel. Two fibronectin-degrading components (Mrs, 150,000 and 120,000) were identified by this technique (Fig.  7) . Activation of these enzymes was absolutely dependent on the treatment of the gel with a reducing agent, since no fibronectin degradation was detected when t agent was omitted during the development of the Proteolytic enzymes of similar sizes degrade copolymerized in polyacrylamide gels (Fig. 7) , a described (13 Previous studies in our laboratory showed that P. gingivalis W12 binds and degrades human fibrinogen (13, 14) 
